Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity
Genetic association studies have focused on testing additive models in cohorts with European ancestry. Little is known about recessive effects on common diseases, specifically for non-European ancestry. Genes & Health is a cohort of British Pakistani and Bangladeshi individuals with elevated rates of consanguinity and endogamy, making it suitable to study recessive effects. We imputed variants into a genotyped dataset (n = 44,190) by using two reference panels: a set of 4,982 whole-exome sequences from within the cohort and the Trans-Omics for Precision Medicine (TOPMed-r2) panel. We performed association testing with 898 diseases from electronic health records. 185 independent loci reached genome-wide significance (p < 5 × 10<sup>-8</sup>) under the recessive model, with p values lower than under the additive model, and >40% of these were novel. 140 loci demonstrated nominally significant (p < 0.05) dominance deviation p values, confirming a recessive association pattern. Sixteen loci in three clusters were significant at a Bonferroni threshold, accounting for multiple phenotypes tested (p < 5.4 × 10<sup>-12</sup>). In FinnGen, we replicated 44% of the expected number of Bonferroni-significant loci we were powered to replicate, at least one from each cluster, including an intronic variant in patatin-like phospholipase domain-containing protein 3 (PNPLA3; rs66812091) and non-alcoholic fatty liver disease, a previously reported additive association. We present evidence suggesting that the association is recessive instead (odds ratio [OR] = 1.3, recessive p = 2 × 10<sup>-12</sup>, additive p = 2 × 10<sup>-11</sup>, dominance deviation p = 3 × 10<sup>-2</sup>, and FinnGen recessive OR = 1.3 and p = 6 × 10<sup>-12</sup>). We identified a novel protective recessive association between a missense variant in SGLT4 (rs61746559), a sodium-glucose transporter with a possible role in the renin-angiotensin-aldosterone system, and hypertension (OR = 0.2, p = 3 × 10<sup>-8</sup>, dominance deviation p = 7 × 10<sup>-6</sup>). These results motivate interrogating recessive effects on common diseases more widely.
Authors
- Daniel Shiloh Malawsky (ORCID: https://orcid.org/0000-0003-4421-8688)
- Klaudia Walter (ORCID: https://orcid.org/0000-0003-4448-0301)
- David A. van Heel (ORCID: https://orcid.org/0000-0002-0637-2265)
- Henrike Heyne (ORCID: https://orcid.org/0000-0001-9893-3850)
- Sarah Finer (ORCID: https://orcid.org/0000-0002-2684-4653)
- Hilary C. Martin (ORCID: https://orcid.org/0000-0002-4454-9084)
- Teng Hiang Heng (ORCID: https://orcid.org/0000-0001-5465-6951)
- Qin Huang (ORCID: https://orcid.org/0000-0003-4139-3819)
- Mark J. Daly (ORCID: https://orcid.org/0000-0002-0949-8752)
- Juha Karjalainen
- Georgios Kalantzis
Institutions
- Broad Institute (US)
- Hasso Plattner Institute (DE)
- Queen Mary University of London (GB)
- Wellcome Sanger Institute (GB)
Publication Details
- Journal
- The American Journal of Human Genetics
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1016/j.ajhg.2025.03.020
- Citations
- 3
- Primary Topic
- Genetic Associations and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Wellcome
- Biogen
- Alnylam Pharmaceuticals
- Celgene
- AbbVie
- Maze Therapeutics
- Novo Nordisk UK Research Foundation
- Agency for Science, Technology and Research
- Novartis Pharma
- Pfizer UK
- Merck Sharp and Dohme
- Medical Research Council
- Janssen Biotech